| 1. |
|
|
| 2. |
- Abe, O, et al.
(författare)
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
- 2005
-
Ingår i: The Lancet. - 1474-547X. ; 365:9472, s. 1687-1717
-
Tidskriftsartikel (refereegranskat)abstract
- Background Quinquennial overviews (1985-2000) of the randomised trials in early breast cancer have assessed the 5-year and 10-year effects of various systemic adjuvant therapies on breast cancer recurrence and survival. Here, we report the 10-year and 15-year effects. Methods Collaborative meta-analyses were undertaken of 194 unconfounded randomised trials of adjuvant chemotherapy or hormonal therapy that began by 1995. Many trials involved CMF (cyclophosphamide, methotrexate, fluorouracil), anthracycline-based combinations such as FAC (fluorouracil, doxombicin, cyclophosphamide) or FEC (fluorouracil, epirubicin, cyclophosphamide), tamoxifen, or ovarian suppression: none involved taxanes, trastuzumab, raloxifene, or modem aromatase inhibitors. Findings Allocation to about 6 months of anthracycline-based polychemotherapy (eg, with FAC or FEC) reduces the annual breast cancer death rate by about 38% (SE 5) for women younger than 50 years of age when diagnosed and by about 20% (SE 4) for those of age 50-69 years when diagnosed, largely irrespective of the use of tamoxifen and of oestrogen receptor (ER) status, nodal status, or other tumour characteristics. Such regimens are significantly (2p=0 . 0001 for recurrence, 2p<0 . 00001 for breast cancer mortality) more effective than CMF chemotherapy. Few women of age 70 years or older entered these chemotherapy trials. For ER-positive disease only, allocation to about 5 years of adjuvant tamoxifen reduces the annual breast cancer death rate by 31% (SE 3), largely irrespective of the use of chemotherapy and of age (<50, 50-69, &GE; 70 years), progesterone receptor status, or other tumour characteristics. 5 years is significantly (2p<0 . 00001 for recurrence, 2p=0 . 01 for breast cancer mortality) more effective than just 1-2 years of tamoxifen. For ER-positive tumours, the annual breast cancer mortality rates are similar during years 0-4 and 5-14, as are the proportional reductions in them by 5 years of tamoxifen, so the cumulative reduction in mortality is more than twice as big at 15 years as at 5 years after diagnosis. These results combine six meta-analyses: anthracycline-based versus no chemotherapy (8000 women); CMF-based versus no chemotherapy (14 000); anthracycline-based versus CMF-based chemotherapy (14 000); about 5 years of tamoxifen versus none (15 000); about 1-2 years of tamoxifen versus none (33 000); and about 5 years versus 1-2 years of tamoxifen (18 000). Finally, allocation to ovarian ablation or suppression (8000 women) also significantly reduces breast cancer mortality, but appears to do so only in the absence of other systemic treatments. For middle-aged women with ER-positive disease (the commonest type of breast cancer), the breast cancer mortality rate throughout the next 15 years would be approximately halved by 6 months of anthracycline-based chemotherapy (with a combination such as FAC or FEC) followed by 5 years of adjuvant tamoxifen. For, if mortality reductions of 38% (age <50 years) and 20% (age 50-69 years) from such chemotherapy were followed by a further reduction of 31% from tamoxifen in the risks that remain, the final mortality reductions would be 57% and 45%, respectively (and, the trial results could well have been somewhat stronger if there had been full compliance with the allocated treatments). Overall survival would be comparably improved, since these treatments have relatively small effects on mortality from the aggregate of all other causes. Interpretation Some of the widely practicable adjuvant drug treatments that were being tested in the 1980s, which substantially reduced 5-year recurrence rates (but had somewhat less effect on 5-year mortality rates), also substantially reduce 15-year mortality rates. Further improvements in long-term survival could well be available from newer drugs, or better use of older drugs.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Huner, Norman P A, et al.
(författare)
-
Photoprotection of Photosystem II: Reaction center quenching versus antenna quenching
- 2006
-
Ingår i: Photoprotection, Photoinhibition, Gene Regulation and Environment. - : Springer. - 9781402035647 ; , s. 155-174
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)abstract
- Photoprotection, Photoinhibition, Gene Regulation, and Environment examines the processes whereby plants monitor environmental conditions and orchestrate their response to change, an ability paramount to the life of all plants. "Excess light", absorbed by the light-harvesting systems of photosynthetic organisms, is an integrative indicator of the environment, communicating the presence of intense light and any conditions unfavorable for growth and photosynthesis. Key plant responses are photoprotection and photoinhibition. In this volume, the dual role of photoprotective responses in the preservation of leaf integrity and in redox signaling networks modulating stress acclimation, growth, and development is addressed. In addition, the still unresolved impact of photoinhibition on plant survival and productivity is discussed. Specific topics include dissipation of excess energy via thermal and other pathways, scavenging of reactive oxygen by antioxidants, proteins key to photoprotection and photoinhibition, peroxidation of lipids, as well as signaling by reactive oxygen, lipid-derived messengers, and other messengers that modulate gene expression. Approaches include biochemical, physiological, genetic, molecular, and field studies, addressing intense visible and ultraviolet light, winter conditions, nutrient deficiency, drought, and salinity. This book is directed toward advanced undergraduate students, graduate students, and researchers interested in Plant Ecology, Stress Physiology, Plant Biochemistry, Integrative Biology, and Photobiology.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Newman, S.T., et al.
(författare)
-
Strategic Advantages of Interoperability for Global Manufacturing Using CNC Technology
- 2008
-
Ingår i: Robotics and Computer-Integrated Manufacturing. - : Elsevier BV. - 0736-5845 .- 1879-2537. ; 24:6, s. 699-708
-
Tidskriftsartikel (refereegranskat)abstract
- In the domain of manufacturing, computer numerically controllers (CNC) technology is a major contributor to the production capacity of the enterprises. The advances in CNC technology coupled with enhancements ill computing systems have provided the basis to re-examine the way in which computer-aided systems (CAx) call be used to enable global manufacturing. Interoperability of the various components of the CAx chain is therefore a major prerequisite for manufacturing enterprises for becoming strategically agile and consequently globally competitive. Being interoperable, resources call be utilized interchangeably in a plug-and-produce manner. Over the last 8 years the eminence of a STEP standard for machining entitled STEP-NC (numerical control) has become a well-known vehicle for research to improve the level of information availability at the CNC machine too]. Ill this paper, the authors introduce the background to the evolution of CNC manufacturing over the last 50 years and the Current standards available for programming. A review of the literature in interoperable CNC Manufacturing is then provided relating to Milling, turn-mill and other NC processes. The major part of the paper provides a strategic view of]low interoperability call be implemented across the CAx chain with a range of standards used to regulate the flow of information. Finally, the paper Outlines the advantages and major issues for future developments in interoperability, identifying future key requirements and limiting factors.
|
|
| 9. |
|
|
| 10. |
- Pokapanich, Wandared, et al.
(författare)
-
Auger Electron Spectroscopy as a Probe of the Solution of Aqueous Ions
- 2009
-
Ingår i: Journal of the American Chemical Society. - : American Chemical Society (ACS). - 1520-5126 .- 0002-7863. ; 131:21, s. 7264-7271
-
Tidskriftsartikel (refereegranskat)abstract
- Aqueous potassium chloride has been studied by synchrotron-radiation excited core-level photoelectron and Auger electron spectroscopy. In the Auger spectrum of the potassium ion, the main feature comprises the final states where two outer valence holes are localized on potassium. This spectrum exhibits also another feature at a higher kinetic energy which is related to final states where outer valence holes reside on different subunits. Through ab initio calculations for microsolvated clusters, these subunits have been assigned as potassium ions and the surrounding water molecules. The situation is more complicated in the Auger spectrum of the chloride anion. One-center and multicenter final states are present here as well but overlap energetically.
|
|
